A compound according to Formula I or a pharmaceutically acceptable salt thereof wherein - A 1 is NR 1 or CR 1 , with R 1 being H or methyl, with methyl, if present, optionally being substituted with one or more F; - the cyclopropyl moiety can be optionally substituted with one or more methyl and one or more F; - A 2 -A 5 are N or CR 2 -CR 5 , respectively, with the proviso that no more than two of the four positions A in A 2 -A 5 can be simultaneously N; - R 2 -R 5 are independently H, halogen, amino, C(1-3)alkoxy, (di)C(1-3)alkylamino or C(1-6)alkyl; - R 6 and R 7 are independently H, F, methyl, ethyl, hydroxyl or methoxy or R 6 and R 7 together is carbonyl, all alkyl groups, if present, optionally being substituted with one or more F; - R 8 is H or C(1-6)alkyl; - A 9 -A 12 are N or CR 9 -CR 12 , respectively, with the proviso that no more than two of the four positions A in A 9 -A 12 can be simultaneously N; - R 9 -R 12 are independently H, halogen, amino, C(1-3)alkoxy, (di)C(1-3)alkylamino or C(1-6)alkyl; - R 13 is H, C(1-6)alkyl, C(2-6)alkenyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-4)alkyl, C(2-5)heterocycloalkyl, C(2-5)heterocycloalkyl-C(1-4)alkyl, C(6-10)aryl, C(6-10)arylC(1-4)alkyl, C(1-9)heteroaryl or C(1-9)heteroarylC(1-4)alkyl, all groups optionally substituted with one or more halogen, amino, hydroxyl, cyano, C(1-3)alkoxy, C(1-3)alkoxycarbonyl, (di)C(1-3)alkylamino or C(1-3)alkyl; and - R 14 is H, C(1-6)alkyl, C(2-6)alkenyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-4)alkyl, C(2-5)heterocycloalkyl, C(2-5)heterocycloalkyl-C(1-4)alkyl, C(6-10)aryl, C(6-10)arylC(1-4)alkyl, C(1-9)heteroaryl or C(1-9)heteroarylC(1-4)alkyl, all groups optionally substituted with one or more halogen, amino, hydroxyl, cyano, C(1-3)alkoxy, C(1-3)alkoxycarbonyl, (di)C(1-3)alkylamino or C(1-3)alkyl; or R 13 and R 14 are fused and form a ring having 5 to 7 atoms by joining R13 being C(1-6)alkyl or C(2-6)alkenyl with an independent substituent within the definition of R14, all groups optionally substituted with one or more halogen, amino, hydroxy, cyano, C(1-3)alkoxy, C(1-3)alkoxycarbonyl, (di)C(1-3)alkylamino or C(1-3)alkyl. - A 1 is NR 1 or CR 1 , with R 1 being H or methyl, with methyl, if present, optionally being substituted with one or more F; - the cyclopropyl moiety can be optionally substituted with one or more methyl and one or more F; - A 2 -A 5 are N or CR 2 -CR 5 , respectively, with the proviso that no more than two of the four positions A in A 2 -A 5 can be simultaneously N; - R 2 -R 5 are independently H, halogen, amino, C(1-3)alkoxy, (di)C(1-3)alkylamino or C(1-6)alkyl; - R 6 and R 7 are independently H, F, methyl, ethyl, hydroxyl or methoxy or R 6 and R 7 together is carbonyl, all alkyl groups, if present, optionally being substituted with one or more F; - R 8 is H or C(1-6)alkyl; - A 9 -A 12 are N or CR 9 -CR 12 , respectively, with the proviso that no more than two of the four positions A in A 9 -A 12 can be simultaneously N; - R 9 -R 12 are independently H, halogen, amino, C(1-3)alkoxy, (di)C(1-3)alkylamino or C(1-6)alkyl; - R 13 is H, C(1-6)alkyl, C(2-6)alkenyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-4)alkyl, C(2-5)heterocycloalkyl, C(2-5)heterocycloalkyl-C(1-4)alkyl, C(6-10)aryl, C(6-10)arylC(1-4)alkyl, C(1-9)heteroaryl or C(1-9)heteroarylC(1-4)alkyl, all groups optionally substituted with one or more halogen, amino, hydroxyl, cyano, C(1-3)alkoxy, C(1-3)alkoxycarbonyl, (di)C(1-3)alkylamino or C(1-3)alkyl; and - R 14 is H, C(1-6)alkyl, C(2-6)alkenyl, C(3-6)cycloalkyl, C(3-6)cycloalkylC(1-4)alkyl, C(2-5)heterocycloalkyl, C(2-5)heterocycloalkyl-C(1-4)alkyl, C(6-10)aryl, C(6-10)arylC(1-4)alkyl, C(1-9)heteroaryl or C(1-9)heteroarylC(1-4)alkyl, all groups optionally substituted with one or more halogen, amino, hydroxyl, cyano, C(1-3)alkoxy, C(1-3)alkoxycarbonyl, (di)C(1-3)alkylamino or C(1-3)alkyl; <EOS>